Delivery Order SPE2DB24D9223-SPE2DB24FKECW

Award Date 9/13/24
Potential Completion Date 10/4/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $17,974.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, with a period of performance through December 9, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price valued at $17,771.40 and has an ultimate completion date of May 19, 2025. The contract is for the provision of 4,568,091,646 units of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. This award is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $26,764.80, is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order that is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order for $11,136.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, with a period of performance through August 30, 2024. This award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,139 contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a period of performance through June 12, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB Indefinite Delivery Contract (IDC). The $17,230.64 award is for the supply of 4,566,174,692 units of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 IDC with the DLA that enables the agency to issue firm fixed-price orders for a...
This is a $17,365.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,565,020,496 units of the prescription drug PROLASTIN C, with a June 18, 2024 completion date. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the DLA to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,365.20 award is for the delivery of 4565030758 PROLASTIN C 1,000 MG/20 ML VLS, which are prescription pharmaceutical products. The order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with DLA to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,192.44, is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialty pharmaceutical product. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with the DLA, worth up to $4,999,999 through the end of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,642.68 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with an ultimate completion date of October 4, 2024. The award is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
  • SPE2DB24D9223
    Indefinite Delivery Contract
  • SPE2DB24D9223-SPE2DB24FKECW
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,400.00, is for the delivery of 4,566,026,441 units of PROLASTIN C 1,000 MG/20 ML VLS, a medication used to treat alpha-1 antitrypsin deficiency.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. This IDC allows the DLA to issue firm fixed-price delivery orders for a variety of medications, including common drugs as well as specialized pharmaceuticals and medical supplies.

The contract does not have a set-aside designation, and DMS Pharmaceutical Group's status as a woman-owned small business allows the company to secure direct awards for the DLA's Medical Supply Chain program, which distributes pharmaceuticals to various Department of Defense (DoD) healthcare facilities globally.

Generated 12/13/24, 9:13 AM